-
Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions
•
Guangzhou-based smart healthcare service platform Fangzhou Inc. (HKG: 6086) has announced a strategic partnership with China Internet giant Tencent’s Tencent Health and Tencent Cloud. The alliance aims to accelerate the development and implementation of AI-driven healthcare solutions by integrating the DeepSeek open-source AI Model on Fangzhou’s platform. Partnership DetailsThrough this…
-
DeepSeek’s Rise in the Pharmaceutical Industry: A New Era of AI-Driven Transformation
•
The emergence of DeepSeek-R1 during the Lunar New Year celebrations marked a pivotal moment in the adoption of affordable, open-source large language models (LLMs). This breakthrough not only lowered the barrier to entry for AI technology but also demonstrated its remarkable potential to revolutionize workflows across industries. The pharmaceutical sector…
-
Ping An Healthcare Reports 2024 Financial Turnaround with Growth in Healthcare Services
•
China-based Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as Ping An Good Doctor, released its 2024 financial report. The company recorded RMB 4.8 billion (USD 664 million) in revenues, marking a 2.9% year-on-year (YOY) increase. Notably, Ping An Healthcare achieved a significant turnaround by posting RMB88.32…
-
Hansoh Pharmaceutical’s Ameile Wins New NMPA Approval for Advanced NSCLC Treatment
•
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) announced receiving another indication approval from the National Medical Products Administration (NMPA) for its Ameile (almonertinib). The epidermal growth factor receptor (EGFR) inhibitor is now approved to treat unresectable locally advanced EGFR exon 19 deletion or exon 21 (L858R) replacement mutation-positive non-small…
-
Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem
•
German pharmaceutical giant Bayer HealthCare (ETR: BAYN) has entered into a new partnership with JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), focusing on women’s health. The collaboration aims to establish a comprehensive health management ecosystem covering the entire life cycle of women, integrating Bayer’s medical expertise…
-
Baidu Health Partners with Jolly Pharma to Boost Digital Drug Marketing
•
Baidu Health, an internet giant, has entered into a partnership with Zhejiang Jolly Pharmaceutical Co., Ltd. Under the agreement, Baidu will leverage its strengths in AI and its internet medicine platform to drive digital marketing innovation for Jolly Pharma’s Bailing capsules and other drugs. The initial focus will be on…
-
Pharmaceutical Giants Race to Integrate DeepSeek AI for Efficiency Gains
•
On February 14, China’s stock market saw a significant upsurge in the AI pharmaceuticals sector, with healthcare stocks across the board performing strongly. The rally was particularly driven by AI Pharmaceuticals, medical services, and DRG/DIP segments, with companies like Shanghai Runda Medical Technology Co., Ltd. leading the charge, resulting in…
-
DeepSeek Enhances Biopharma IND and NDA Processes with AI
•
In the regulatory submissions for Investigational New Drug (IND) and New Drug Application (NDA) in the biopharmaceutical sector, DeepSeek, as an AI technology tool or service platform, can enhance the efficiency and compliance of the application process through the following means: Data Management and Analysis Document Automation and Compliance Support…
-
China Medical System Partners with MabGeek for Innovative Drug MG-K10
•
China Medical System Holdings (CMS; HKG: 0867) has announced a new license agreement with MabGeek Biotechnology Co., Ltd., a fellow Chinese biotech firm, for the latter’s Category 1 drug MG-K10. This marks CMS’s second major licensing deal in less than a month. Financial details of the agreement were not disclosed.…
-
Sanofi and Corxel Pharmaceuticals Partner for Aficamten in Greater China Rights
•
Global healthcare leader Sanofi (NASDAQ: SNY) and China-based Corxel Pharmaceuticals (CORXEL), formerly known as Ji Xing Pharmaceuticals, have jointly announced an official agreement. Under this partnership, Sanofi is set to acquire exclusive development and commercialization rights to CORXEL’s aficamten in Greater China. The financial details of the deal have not…
-
111 Inc. Appoints Yang “Luke” Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen
•
China-based online pharmacy 111 Inc. (NASDAQ: YI) has announced the appointment of its Senior Finance Executive, Mr. Yang “Luke” Chen, as a new director. This follows the resignation of Dr. Leon Lian Yong Chen from the company’s board due to personal reasons, effective immediately. Dr. Lian Yong Chen’s Background and…
-
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the Hong Kong stock exchange (HKG: 9955), has announced that it has secured marketing approval from the National Medical Products Administration (NMPA) for its innovative digital medicine product, ClouDT-01, designed for the treatment of diabetes. Leveraging…
-
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
•
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant Alibaba Group, has announced strategic collaboration agreements with a consortium of pharmaceutical companies. The collaborations include US-based Viatris (NASDAQ: VTRS) and Chinese firms Qilu Pharmaceutical, Chongqing Taiji Industry (Group) Co., Ltd (SHA: 600129), Shandong Dyne…
-
Ant Group Eyes Acquisition of Leading Internet Healthcare Platform Haodf.com
•
Ant Group, the China-based fintech powerhouse, is reportedly pursuing the acquisition of Haodf.com, one of the country’s leading Internet healthcare platforms. This shift in negotiations comes after Alibaba Health Information Technology Ltd (HKG: 0241), Ant’s sister company, previously engaged in discussions with Haodf.com, according to local media sources. The two…
-
Shanghai Pharmaceuticals’ SH-INNO Incubator to Drive Biopharmaceutical Innovation and Collaboration
•
Shanghai Pharmaceuticals (SPH;HKG: 2607; SHA: 601607) has launched the “SH-INNO incubator,” a collaborative initiative with premier academic institutions and leading scientific research organizations. The incubator is designed to dismantle conventional silos and foster interdisciplinary collaboration among professionals, scholars, corporations, and financiers across the spectrum of “industry, academia, research, medicine, and…
-
WeDoctor Partners with Shanghai Children’s Medical Center to Enhance Pediatric Care
•
WeDoctor Holdings Ltd, a subsidiary of Chinese internet conglomerate Tencent Corporate Venture Capital (HKG: 0700) that specializes in online medical services, has entered into a strategic partnership with Shanghai Children’s Medical Center. While financial details of the agreement were not disclosed, the collaboration aims to combine WeDoctor’s expertise in digitalization…
-
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
•
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured nearly RMB 100 million (USD 13.8 million) in a Series C financing round. The funding round attracted notable investors such as Ameba Capital, Ventech China, and Borchid Capital. The capital raised is intended to fuel…
-
Digital Health China Partners with Huawei to Launch Intelligent Multimodal Big Data System for Healthcare
•
Digital Health China Technologies Co., Ltd., a leading cloud-based healthcare service provider based in China, has entered into a comprehensive partnership agreement with Huawei Technologies Co., Ltd., a global telecommunications giant. The collaboration aims to jointly launch an intelligent multimodal big data center system solution. This innovative solution harnesses the…
-
Winning Health Partners with Unicom Digitization Medical to Boost Medical Industry Innovation
•
Winning Health (SHE: 300253), a Shanghai-based company in the medical information industry, has entered into a partnership with Unicom Digitization Medical Technology Co., Ltd. The collaboration aims to combine their respective strengths in the medical and health sector to enhance product, service, and commercial innovation. The joint efforts will focus…
-
Eli Lilly & Co. Partners with OpenAI to Use Generative AI in Antimicrobial Drug Discovery
•
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company based in the U.S., has announced a drug collaboration agreement with OpenAI, a prominent artificial intelligence (AI) research organization headquartered in San Francisco. As part of this collaboration, Lilly will utilize OpenAI’s advanced generative AI technologies to develop innovative antimicrobial…
